
Novonesis Investor Relations Material
Latest events

Q1 2025
Novonesis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Novonesis
Access all reports
Novonesis develops, produces and sells industrial enzymes, microorganisms and probiotics. The products convert raw materials into food, beverages and biofuels; they also improve the production of crops and plant products, as well as animal feed. Manufacturing microorganisms, enzymes and probiotics for the industrial, biotech and food markets, Novonesis creates innovative solutions that improve their customers' fermentation processes. Their development centres in Europe, USA and Asia help the company to develop consistent and cost-efficient solutions for their partners worldwide.
Key slides for Novonesis


M&A Announcement
Novonesis


Q1 2025
Novonesis
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
NSIS
Country
🇩🇰 Denmark